Covid-19 mRNA vaccines are “exactly the same” as iPhones, according to Moderna CEO Stéphane Bancel, who told CNN viewers they should get used to updating their vaccination status every September, in the same way they purchase new cell phones.
Appearing on CNN Business this week, Bancel told viewers that Moderna will “keep updating the vaccines” in order to roll out “a single-dose annual booster to cover the coronavirus, the flu and another common respiratory virus within the next five years.”
“You don’t get the amazing camera, amazing everything the first time you get an iPhone, but you get a lot of things,” he said.
“A lot of us buy a new iPhone every September, and you get new apps and you get refreshed apps,” Bancel explained. “That’s exactly the same idea, which is you’ll get Covid and flu and RSV [respiratory syncytial virus] in your single dose.”
“We think we can put in a single product a lot of mRNAs, taking care of all of those viruses. And that’s once a year. You should be able to get an annual booster, a single dose, that has, in the vial, all those mRNAs for all those viruses that are, of course, adapted to the strain of a season like flu, like COVID strain, and so on,” Bancel said.
RELATED: Scientists Find Covid-19 Contains DNA Code Patented By Moderna YEARS Before Pandemic Began
Bancel admitted many people in the future could choose to live with Covid-19 in the same way people have chosen to live with the flu in the past.
“I think we are slowly moving — if not already in some countries — to a world where all the tools are available, and everybody can make their own decision based on their risk tolerance.”
In February, further evidence that we have not been told the truth about the origins of Covid-19 emerged after scientists found genetic material patented by Moderna in 2016 in the virus’s spike protein. According to researchers, there is a “one-in-three-trillion chance” of this “coincidence” evolving naturally.
The team of international researchers identified a tiny snippet of code that is identical to part of a gene patented by Moderna three years before the pandemic.
Leave a Reply